Seon Young Kim

3 weeks ago | nature.com | Seon Young Kim |Yiyoung Kwon |Eun Sil Kim |Yoon Kim |Hansol Kim |Yon Ho Choe

AbstractA pilot study investigated the cytokine profile (IL-6, TNF-α, IL-17 A, and IL-10) at diagnosis, affecting infliximab (IFX) trough levels (TLs) in pediatric patients with Crohn’s disease (CD). In this follow-up study, we evaluated the changes in cytokine level changes after Crohn’s disease treatment. Cytokines were re-measured after 1 year of treatment. infliximab trough levels and total anti-infliximab antibodies were also measured in patients who had started infliximab treatment.

Mar 7, 2024 | mdpi.com | Juhyun Shin |Jun Lee |Wahn Soo Choi |Seon Young Kim

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.